Broadfin Capital »

Anaptysbio Inc Common shares owned by Broadfin Capital

Quarter-by-quarter ownership of Anaptysbio Inc Common (ANAB) shares owned by Broadfin Capital from 13F filings

Historical chart of Broadfin Capital investment in Anaptysbio Inc Common

Tip: Access up to 7 years of quarterly data

All positions including Anaptysbio Inc Common held by Broadfin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anaptysbio Inc Common by Broadfin Capital

Quarter filed Position value Share count Share price at filing
2019-12-31 $3.6M 222k 16.25
2018-03-31 $8.2M 79k 104.08

More positions owned by Broadfin Capital

Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Biohaven Pharmaceutical Holding
SPDR S&P Biotech (XBI)
BioDelivery Sciences International
Alkermes (ALKS)
Viewray (VRAYQ)
Amarin Corporation (AMRN)
Quotient
Eiger Biopharmaceuticals
STAAR Surgical Company (STAA)
Intersect Ent
Progenics Pharmaceuticals
Nanostring Technologies (NSTGQ)
Iovance Biotherapeutics (IOVA)

View all positions for Broadfin Capital

Top funds holding Anaptysbio Inc Common

EcoR1 Capital
Tang Capital Management
Vanguard Group
Boxer Capital
First Light Asset Management
Dr. Jeffrey R. Jay, M.D.
Frazier Life Sciences Management
Point72 Asset Management
Palo Alto Investors
Dimensional Fund Advisors
Eventide Asset Management
Millennium Management
Franklin Resources
5AM Venture Management
Blackstone Group

View all funds holding Anaptysbio Inc Common